Dr. Thomas Blackburn

    Dr. Thomas Blackburn is an expert in equity markets and portfolio management, holding a Ph.D. in Financial Economics from Columbia University. With over 18 years of experience in asset management and financial advisory, Thomas has a deep understanding of share valuation, risk assessment, and capital markets. He is currently the Chief Investment Officer at a renowned investment firm, where he oversees multimillion-pound portfolios and advises institutional clients on investment strategies. Thomas is known for his pragmatic approach to investment and frequent contributions to financial journals, offering insights into effective asset diversification and risk management.

    Jim Cramer’s Surprising Take on Qualcomm Amidst AI Stock Chaos

    Jim Cramer’s Surprising Take on Qualcomm Amidst AI Stock Chaos

    Jim Cramer provides valuable insights amid the AI stock sell-off, questioning the sustainability of GPU orders. The simultaneous decline in “traveller stocks” and nuclear investments signals potential market hype and excess. Cramer’s disappointing experience with DeepSeek’s AI model raises concerns about the
    31. Січня 2025
    Shock on the ASX! One Healthcare Stock is Crashing

    Shock on the ASX! One Healthcare Stock is Plummeting

    Neuren Pharmaceuticals Faces Major Setback Trading began positively for the S&P/ASX 200 Index, but by afternoon, the index’s optimism faded, remaining nearly unchanged at 8,226 points. Among the day’s significant disappointments is Neuren Pharmaceuticals Ltd, which is witnessing a dramatic decline in
    16. Січня 2025
    Nubank Soars on NYSE Debut. What Investors Need to Know

    Nubank S’oars on NYSE Debut. What Investors Need to Know

    Nubank, the renowned Brazilian fintech giant, made waves as it marked its debut on the New York Stock Exchange (NYSE), capturing the attention of global investors. Having started as a digital-first bank, Nubank’s rapid rise is a testament to the growing influence
    4. Січня 2025

    Languages